Year: 2026

Humanity’s most distant spacecraft continues its solitary voyage beyond the solar system’s edge, and engineers must now make difficult calls about which instruments should be shut down to prolong its travels. Each decision involves a delicate balance between safeguarding the craft and uncovering fresh discoveries at the universe’s remote frontier.As it continues its trek through interstellar space, Voyager 1 has moved into a fresh operational phase focused on preserving limited resources instead of expanding capabilities, and in mid-April, NASA engineers issued a command to power down one of the spacecraft’s scientific instruments to conserve energy and prolong its working life,…

Artificial intelligence workloads have reshaped how cloud infrastructure is designed, deployed, and optimized, prompting serverless and container-driven platforms once focused on web and microservice applications to rapidly evolve to meet the unique demands of machine learning training, inference, and data-intensive workflows; these needs include extensive parallel execution, variable resource usage, ultra‑low‑latency inference, and frictionless connections to data ecosystems, leading cloud providers and platform engineers to rethink abstractions, scheduling methods, and pricing models to better support AI at scale.Why AI Workloads Stress Traditional PlatformsAI workloads differ from traditional applications in several important ways:Elastic but bursty compute needs: Model training can demand…

Obesity and excess weight are chronic, relapsing conditions with complex biological, environmental, and behavioral drivers. Medications for weight management are increasingly important tools that can produce clinically meaningful weight loss, improve metabolic health, and reduce disease burden when used as part of a broader treatment plan. This article explains how these drugs work, summarizes evidence of benefit, lists key risks, and sets realistic expectations for patients and clinicians.How weight-loss medications operateMedications target different physiological pathways that regulate appetite, satiety, digestion, and energy balance:Appetite-suppressing incretin receptor agonists (GLP-1 and dual GLP-1/GIP agonists) reduce hunger, promote fullness, and slow gastric emptying.Central nervous…